tiprankstipranks
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Ownership - Who Owns Allogene Therapeutics?

1,228 Followers

Allogene Therapeutics (ALLO) Ownership Overview

31.74%24.63%33.75%9.88%
31.74% Insiders
33.75% Other Institutional Investors
9.88% Public Companies and Individual Investors
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail and individual investors. Approximately 58.38% of the company’s stock is owned by Institutional Investors, 31.74% is owned by Insiders and 9.88% is owned by Public Companies and Individual Investors.
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail and individual investors. Approximately 58.38% of the company’s stock is owned by Institutional Investors, 31.74% is owned by Insiders and 9.88% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 03, 2024
Franz Humer
Director
Sold$26096
May 20, 2024Bought$4999997
Mar 06, 2024Bought$682
Aug 09, 2023
Stephen Mayo
Director
Sold$42800

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Sold$133273
Mar 31, 2024Sold$1927401
Mar 31, 2024Bought$11773872
Mar 31, 2024Bought$24354285

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,861,333Institution4.72%25,146,399
7,099,543Institution3.40%18,103,835
6,837,669Institution3.27%17,436,056
6,277,888Institution3.01%16,008,614
5,448,386Institution2.61%13,893,384
5,310,109Institution2.54%13,540,778
4,728,615Institution2.26%12,057,968
4,121,552Institution1.97%10,509,958
3,604,600Institution1.73%9,191,730
3,410,455Institution1.63%8,696,660

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,099,543Institution3.40%18,103,835
6,277,888Institution3.01%16,008,614
5,310,109Institution2.54%13,540,778
4,121,552Institution1.97%10,509,958
3,604,600Institution1.73%9,191,730
3,410,455Institution1.63%8,696,660
3,393,879Institution1.63%8,654,391
2,870,342Institution1.37%7,319,372
2,002,048Institution0.96%5,105,222
1,881,671Institution0.90%4,798,261

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,434,577Institution3.08%15,700,368
4,337,709Institution2.08%10,844,273
2,220,760Institution1.06%5,662,938
1,848,593Institution0.89%4,621,483
1,701,419Institution0.81%4,253,548
1,051,127Institution0.50%2,627,818
894,211Institution0.43%2,280,238
835,104Institution0.40%2,129,515
535,157Institution0.26%1,305,783
495,733Institution0.24%1,239,333

FAQ

Who Owns Allogene Therapeutics Inc (ALLO)?
According to the latest TipRanks data, approximately 33.75% of the company's stock is held by institutional investors, 31.74% is held by insiders, and 9.88% is held by retail investors.
    What percentage of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 33.75% of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors.
      What percentage of Allogene Therapeutics Inc (ALLO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 9.88% of Allogene Therapeutics Inc (ALLO) stock is held by retail investors.
        Who owns the most shares of Allogene Therapeutics Inc (ALLO)?
        Vanguard owns the most shares of Allogene Therapeutics Inc (ALLO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis